Home > Food & Beverages > Nutraceuticals > Probiotics Market
Probiotics Market size was valued at USD 5.56 billion in 2023 and is projected to register 6.9% CAGR from 2024 to 2032, driven by increasing awareness and research on their health benefits for medical conditions. Probiotics are beneficial bacteria that support gut health, improve digestive health, help combat autoimmune conditions, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD), and are also strongly associated with preventing anxiety and depression.
For instance, in May 2024, according to systematic reviews and meta-analyses, probiotics showed benefits for patients with ulcerative colitis, including reversal of hepatic encephalopathy (HE), improvement of liver function measures, and monitoring of gut modifications in addition to better protection against allergies. The study authors said probiotics have shown potential as a promising treatment for the condition.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Probiotics Market Size in 2023: | USD 5.56 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 6.9% |
2032 Value Projection: | USD 10.28 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 328 |
Tables, Charts & Figures: | 418 |
Segments covered: | Ingredients, Application, End Use |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
This increase in scientific evidence increased consumer confidence in probiotics, leading to increased demand. Consumers are seeking natural and preventative health solutions and see probiotics as a crucial component of overall health. The food and beverage and the nutritional supplement industry have responded by introducing a range of probiotic-rich products, from yogurt and kefir to capsule gummies. This expansion in the supply chain has led to probiotics being widely available, allowing market growth to be achieved.
The probiotics market is facing several restraints despite its rapid growth. Regulatory challenges are considerable, as probiotic products must meet stringent safety and efficacy standards set by health authorities, which can delay product approvals and increase costs. Additionally, consumer uncertainty regarding health claims by probiotic manufacturers may restrict market expansion.
The lack of standardized guidelines for probiotic strains and dosages further complicates consumer confidence and product development. Furthermore, the stability of probiotics during processing and storage poses challenges, as the amount of bacteria that can be retained until consumption is critical to its effectiveness. All these factors hinder the overall potential of the market.